ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
93 hedge funds and large institutions have $316M invested in Adamas Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
12% more funds holding
Funds holding: 83 → 93 (+10)
12% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 25
Holders
93
Holding in Top 10
3
Calls
$831K
Puts
$104K
Top Buyers
| 1 | +$9.27M | |
| 2 | +$9.05M | |
| 3 | +$6.54M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$6.5M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.25M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$4M | |
| 3 | -$2.83M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.79M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.55M |